Stai per lasciare il sito web LMCome di proprietà di Janssen-Cilag S.p.A.

Le informazioni contenute nel sito web a cui stai per accedere potrebbero non essere conformi alla normativa vigente in materia di pubblicità sui medicinali.

Janssen-Cilag SpA non è responsabile dell 'attendibilità o correttezza dei contenuti del sito web a cui ti porterà il link né sarà più applicabile la Privacy Policy di questo sito.

Clicca sul link per continuare.

MALATTIE EMATOLOGICHE

FONTI E BIBLIOGRAFIA

Consulta le fonti delle informazioni che trovi su questo sito

Leucemia Linfatica Cronica #CLL

American Cancer Society. Chronic Lymphocytic Leukemia (CLL): Early Detection, Diagnosis, and Staging (Ultimo accesso 06 Febbraio 2019).

American Cancer Society. Leukemia - Chronic Lymphocytic (Ultimo accesso 10 Gennaio 2019).

American Cancer Society. Living As a Chronic Lymphocytic Leukemia Survivor (Ultimo accesso 23 Dicembre 2018).

Associazione Italiana contro le Leucemie-linfomi e mieloma AIL. Patologie ematologiche (ultimo accesso 10 Gennaio 2019).

Associazione Italiana Malati di Cancro AIMaC. Leucemia linfatica cronica (Ultimo accesso 06 Febbraio 2019).

Associazione Italiana per la Ricerca sul Cancro (AIRC). Leucemia linfatica cronica (Ultimo accesso 02 Febbraio 2019).

Bisceglie V, Albamonte I, Nuove terapie per la cura della leucemia scoperta dai ricercatori dell’Università di Bari, Università degli Studi di Bari Aldo Moro, comunicato stampa del 21 Dicembre 2016.

Canadian Cancer Society. Prognosis and survival for chronic lymphocytic leukemia (Ultimo accesso 13 Dicembre 2018).

Cancer Research UK. Survival (Ultimo accesso 01 Febbraio 2019).

Cancer Research UK. ​Living with chronic lymphocytic leukaemia, 2017.

Hallek M. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Am J Hematol 2015; 90 (5): 446-460.

Hallek M et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111 (12): 5446-5456.

Leucemia linfatica cronica. Seminari di ematologia oncologica Vol. 7 - n. 3 - 2010.

Leukemia & Lymphoma Society. Chronic Lymphocytic Leukemia (Ultimo accesso 09 Gennaio 2019).

Lobetti-Bodoni C et al. The changing paradigm of CLL management. Eur J Intern Med. 2013; 24 (5): 401-410.

Lymphoma Association. Nausea and vomiting, Novembre 2015.

Mayo Clinic. Chronic Lymphocytic Leukemia - Preparing for your appointment (Ultimo accesso 22 Dicembre 2018).

Mayo Clinic. Chronic Lymphocytic Leukemia. Tests and diagnosis (Ultimo accesso 10 Gennaio 2019)

Minervini A, Minervini CF, Anelli L, Zagaria A, Casieri P, Coccaro N, Cumbo C, Tota G, Impera L, Orsini P, Brunetti C, Giordano A, Specchia G, Albano F, Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia, Oncotarget, Novembre 2016. doi: 10.18632/oncotarget.13246.

National Cancer Institute. Cancer Survival Statistics (Ultimo accesso13 Dicembre 2018).

National Cancer Institute. Chronic Lymphocytic Leukemia Treatment (PDQ®). http://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq (ultimo accesso 10 Gennaio 2019)

National Coalition for Cancer Survivorship (NCCS). Living With Chronic Lymphocytic Leukemia (CLL) Resource Booklet, 2013.

National Comprehensive Cancer Network NCCN. Non-Hodgkin’s Lymphomas, version 4/2014.

Norris K, Hillmen P, Rawstron A, et al. Telomere length predicts for outcome to FCR chemotherapy in CLL, Leukemia, 2019; s41375. doi: 10.1038/s41375-019-0389-9.

Osservatorio Malattie Rare OMARLeucemia Linfatica Cronica (Ultimo accesso 14 Dicembre 2018).

Smolewski P et al. New insights into biology, prognostic factors, and current therapeutic strategies in chronic lymphocytic leukemia. ISRN Oncol. 2013; 2013: 740615.

St. John TM, Lymphoma Cancer Signs & Symptoms, LiveStrong.com, 16 Giugno 2016.

Mieloma Multiplo #MM

Adrich K, Hegenbart U, Kimmich C, Kedia N, Bergen HR, Schönland S, Wanker EE, Bieschke J, Aggregation of Full Length Immunoglobulin Light Chains from AL Amyloidosis Patients Is Remodeled by Epigallocatechin-3-gallate, J. Biol. Chem. 2016; 292(6): 2328-2344. doi: 10.1074/jbc.M116.750323.

Alexander DD et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 2007; 120; Suppl 12:40-61.

American Cancer Society. Lifestyle Changes After Having Multiple Myeloma, 2016.

American Cancer SocietyMultiple Myeloma (Ultimo accesso 13 Dicembre 2018).

Associazione Italiana contro le Leucemie-Linfomi e Mieloma AIL. Mieloma Multiplo (Ultimo accesso 12 Dicembre 2018).

Baker T, Looking at the urine and blood may be best in diagnosing myeloma, JAGWire, comunicato stampa del 13 Luglio 2018.

Birmann BM, Andreotti G, De Roos AJ, et al. Young adult and usual adult body mass index and multiple myeloma risk: a pooled analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol Biomarker Prev. 2017; 26(6): 876-885. doi: 10.1158/1055-9965.EPI-16-0762-T.

Bladé J, Rosiñol L. Complications of multiple myeloma. Hematol Oncol Clin North Am 2007; 21(6): 1231-1246, xi.

Cancer.Net. Multiple Myeloma: Statistics (Ultimo accesso13 Dicembre 2018).

Cancer.Net. Multiple Myeloma: Survivorship (Ultimo accesso 13 Dicembre 2018).

Cancer Research UK. Myeloma (Ultimo accesso 13 Dicembre 2018).

Cancer Research UK. Myeloma - Survival (Ultimo accesso 18 Dicembre 2018).

D’Sa S et al. Guidelines for the use of imaging in the management of myeloma. Br J Haematol 2007;137(1):49-63.

Dimopoulos M et al. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop ConsensusPanel 3. Blood 2011;117(18):4701-4705.

Goldschmidt N, Zamir L, Poperno A, Kahan NR, Paltiel O, Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis, J. Am. Board Fam. Med. 2016; 29(6): 702-709. doi: 10.3122/jabfm.2016.06.150393.

Greipp PR et al. International staging system for multiple myeloma. J Clin Oncol. 2005; 23(15): 3412-3420.

Healthline. Diet Tips for Multiple Myeloma, 2018.

Kyle RA, Gertz et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003; 78(1): 21-33.

Lee WS, Singh G. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies. J Clin Med Res. 2018; 10(7): 562-569. doi: https://doi.org/10.14740/jocmr3383w.

Leukemia & Lymphoma Society. ​Facts and Statistics (Ultimo accesso 29 Ottobre 2018).

Ludwig H, Zojer N. Supportive care in multiple myeloma. Best Pract Res Clin Haematol 2007; 20(4): 817-835.

Maddocks ODK, Athineos D, Cheung EC, et al. Modulating the therapeutic response of tumors to dietary serine and glycine starvation. Nature. 2017; 544(7650):372-376. doi: 10.1038/nature22056.

Mikhael JR et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clinic proceedings 2013; 88(4): 360-76.

Monaghan C, Dana-Farber to present research on myeloma progression from precursor conditions, Dana-Farber Cancer Institute, comunicato stampa del 03 Dicembre 2018.

Multiple Myeloma Research Foundation. ​Multiple Myeloma Symptoms (Ultimo accesso 01 Febbraio 2019).

Myeloma Crowd. Malnutrition Among Cancer Patients, 2017.

O’Connell T et al. Understanding and interpretingserum protein electrophoresis. American Family Physician 2005;71(1):105-112.

Osservatorio Malattie Rare OMAR. Mieloma Multiplo, ogni anno in Italia 5 mila nuovi casi, 10 Aprile 2018.

Phekoo KJ et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol. 2004; 127(3): 299-304.

Qasaimeh MA, Wu YC, Bose S, et al.  Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device. Scientific Reports. 2017; 7: 45681. doi: 10.1038/srep45681.

Rajkumar SV, Buadi F. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation. Best Pract Res Clin Haematol .2007;20(4):665-680.

Rajkumar SV et al. International Myeloma Working Group updated criteria for thediagnosis of multiple myeloma. Lancet Oncology 2014; 15(12): e538-e48.

Rajkumar SV. Multiple myeloma: 2012 update on diagnosis, risk-stratificationand management. American Journal of Hematology 2012; 87: 79-88. doi: 10.1002/ajh.22237.

Riccardi AP, Gobbi G. et al. Changing clinical presentation of multiple myeloma. Eur J Cancer 1991; 27(11): 1401-1405.

Smith A et al. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006; 132(4): 410-451.

Spencer Scott P, Health Benefits of Green Tea, WebMD, 2013.

Zavidij O, Haradhvala N, Mouhieddine TH, et al. Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma, ASH Annual Meeting, 02 Dicembre 2018.

Linfoma a Cellule Mantellari #MCL

OrphaNet. Linfoma a cellule mantellari (Ultimo accesso 13 Dicembre 2018).

Boyle T, Gallagher RP, Gascoyne RD, Connors JM, Le ND, Spinelli JJ. Lifetime Physical Activity and the Risk of Non-Hodgkin Lymphoma, Cancer Epidemiol Biomarkers Prev. 2015; 24(5): 873-877; doi: 10.1158/1055-9965.EPI-14-1303.

Dangor J, Increasing physical activity improves survival in lymphoma patients, Mayo researchers sayMayo Clinic, comunicato stampa del 12 Dicembre 2017.

Davis CP, Mantle Cell Lymphoma (MCL), MedicineNet (Ultimoa accesso 10 Dicembre 2018).

Etter JL, Cannioto R, Soh KT, et al. Lifetime physical inactivity is associated with increased risk of Hodgkin and non-Hodgkin lymphoma: a case-control study. Leuk Res. 2018; 69: 7-11. doi: 10.1016/j.leukres.2018.03.014.

Hadrabova M, Janikova A, Stastna J, et al.  P. The importance of physical activity in adult lymphoma survivors—Single center's experience with the supervised aerobic and resistance training program. Hematological Oncology, 2017: 35(S2): 307-308. doi: 10.1002/hon.2439_43.

Haematological Malignancy Research Network HMRN. Survival (Ultimo accesso 10 Dicembre 2018).

Hitz F et al. Diagnosis and treatment of mantle cell lymphoma. Swiss Med Wkly 2013;143: w13868.

Hoster E, Dreyling M, Klapper W, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma, Blood. 2008; 111(2): 558-65. doi: 10.1182/blood-2007-06-095331.

LaCasce A, Mantle cell lymphoma, Cancer Therapy Advisor (Ultimo accesso 10 Dicembre 2018).

Leukemia & Lymphoma Society. Mantle cell lymphoma Facts. No 4, 2014 (Ultimo accesso 05 Febbraio 2019).

Lymphoma Action. Mantle cell lymphoma (Ultimo accesso 10 Dicembre 2018).

Lymphoma Research Foundation. ​Lymphoma Facts, 2005.

Pophali P, Larson MC, Rosenthal AC, et al. The Level of Physical Activity before and after Lymphoma Diagnosis Impacts Overall and Lymphoma-Specific Survival. Blood, 2017; 130:914.

Riley L, Lifetime intense physical activity may lower risk for non-Hodgkin lymphomaAmerican Association for Cancer Research, comunicato stampa del 1 Maggio 2015

Vose JM, Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management, Am J Hematol. 2017; 92(8): 806-813. doi: 10.1002/ajh.24797.

Macroglobulinemia di Waldenström #WM

American Cancer Society. What Are the Key Statistics About Waldenstrom Macroglobulinemia? (Ultimo accesso 15 Dicembre 2018).

Anderson KC et al. Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2/2013. J Natl Compr Canc Netw 2012; 10(10): 1211-9.

Ansell SM et al. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc 2010; 85(9): 824-33.

Associazione Italiana contro le Leucemie-Linfomi e Mieloma AILMacroglobulinemia di Waldenstrom (Ultimo accesso 05 Dicembre 2018).

Associazione Malattia del Sangue (AMS) Onlus. Gruppo Supporto Pazienti WM-Italy (Ultimo accesso 02 Febbraio 2019).

Bustoros M, Sklavenitis-Pistofidis R, Liu C, et al. Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia, ASH Annual Meeting, 01 Dicembre 2018.

D'Souza A, et al. Waldenström macroglobulinaemia: the key questions. Br J Haematol 2013; 162(3): 295-303.

Dimopoulos MA et al. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood 2014; 124(9): 1404-11.

Fondazione IRCCS Policlinico San Matteo - Ematologia. ​Macroglobulinemia di Waldenström: Domande frequenti (Ultimo accesso 05 Gennaio 2019).

Gertz MA. Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012; 87(5): 503-10.

Gertz MA. Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management. Am J Hematol 2013; 88(8): 703-11.

Ghobrial IM. Are you sure this is Waldenström macroglobulinemia? Hematology Am Soc Hematol Educ Program 2012: 586-94.

International Waldenstrom’s Macroglobulinemia Foundation IWMF. Causes, Risk Factors and Prognosis (Ultimo accesso 15 Gennaio 2019).

International Waldenstrom's Macroglobulinemia Foundation IWMF. Macroglobulinemia di Waldenström (Ultimo accesso 05 Febbraio 2019).

International Waldenstrom’s Macroglobulinemia FoundationMacroglobulinemia di Waldenström - Scheda informativa (Ultimo accesso 06 Febbraio 2019).

Janz S. Waldenström Macroglobulinemia: Clinical and Immunological Aspects, Natural History, Cell of Origin, and Emerging Mouse Models. ISRN Hematol 2013: 1-25.

Kyle RA et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IWMG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010; 24(6): 1121-7.

Kyle RA et al. Progression in smoldering Waldenström macroglobulinemia: long-term results. Blood 2012; 119(19): 4462-6.

Leukemia & Lymphoma Society. Waldenström Macroglobulinemia Facts (Ultimo accesso 01 Febbraio 2019).

McMaster ML, Landgren O. Prevalence, clinical aspects, and natural history of IgM MGUS. Cytometry B Clin Cytom 2010; 78(Suppl 1): S91-7.

National Comprehensive Cancer Network NCCN. ​Waldenström’s Macroglobulinemia, Lymphoplasmacytic Lymphoma (Ultimo accesso 06 Febbraio 2019).

National Institutes of Health NIH. Waldenstrom macroglobulinemia (Ultimo accesso 05 Dicembre 2018).

OrphaNet. Macroglobulinemia di Waldenström (Ultimo accesso 05 Dicembre 2018).

Sarlo C, Avvisati G, Macroglobulinemia di Waldenström, Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL) Onlus, consultato il 05 Dicembre 2018

Seiter K, Waldenstrom Macroglobulinemia, Medscape, consultato il 05 Dicembre 2018

Waldenstrom’s Macroglobulinemia Foundation of Canada WMFCLa Macroglobulinemia di Waldenström: Domande e risposte, 2014.

Leucemia Mieloide Acuta #AML

Abelson S, Collord G, Ng SWK, et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature, 2018; 559: 400-404. (Abstract).

American Cancer Society. Key Statistics for Acute Myeloid Leukemia (AML), 21 Agosto 2018.

American Cancer Society. Living as an Acute Myeloid Leukemia (AML) Survivor  (Ultimo accesso 21 Agosto 2018).

Appelbaum FR et al. Age and acute myeloid leukemia. Blood 2006;107:(9):3481-5.

Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL). ​Scoperta senza precedenti sulla leucemia acuta mieloide, AIL Sezione di Pesaro, 20 Dicembre 2016.

Associazione Italiana contro le Leucemie-Linfomi e Mieloma AILLeucemia mieloide cronica (Ultimo accesso 10 Dicembre 2018).

Bear MR, Greer JP. Acute myeloid leukemia in adults. In: Wintrobe’s Clinica! Hematology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009. p.1843-88.

Betz BL, Hess JL. Acute myeloid leukemia diagnosis in the 21st century. Arch Pathol Lab Med 2010;134(10):1427-33.

Blumenfeld Z, Fertility Preservation in Leukemia, The Oncologist 2018; 23: 645-646. doi: 10.1634/theoncologist.2017-0635.

Cancer.Net. Leukemia - Acute Myeloid - AML: Statistics (Ultimo accesso 31 Dicembre 2018).

Cancer Research UK. Acute myeloid leukaemia (AML) - Survival, 06 Luglio 2016.

Cheson BD et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003; 21(24): 4642-9.

de Jonge HJ, Huls G, de Bont ES. Gene expression profiling in acute myeloid leukaemia. Neth J Med. 2011, Apr; 69(4): 167-76.

Deschler B, Lübbert M. Acute myeloid leukemia: Epidemiology and etiology. Cancer 2006;107(9):2099-107.

Dohner H et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European Leukemianet. Blood 2010;115(3):453-74.

Elisei F, Polveri e leucemia: importante scoperta scientifica a Pesaro, Il Foglia, 20 Dicembre 2016.

Ferrara F. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia? Hematol Oncol 2014 32:1–9.

Ferrara F et al. Consensus-based definition of unfitness to intensive and non intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making. Leukemia 2013; 27: 997–999.

Ford D, Easton DF. The genetics of breast and ovarian cancer. Br J Cancer 1995, Oct; 72(4): 805-12.

Gray L. Potential seen for tailoring treatment for acute myeloid leukemia, University of Washington Medicine, comunicato stampa del 05 Dicembre 2018.

Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology, Am Soc Hematol Educ Program 2009:385-95.

Klepin HD, Danhaure SC, Tooze JA, et al. Exercise for older adult inpatients with acute myelogenous leukemia: A pilot study. J Geriatr Oncol. 2011 Jan; 2(1): 11–17. doi: 10.1016/j.jgo.2010.10.004.

Li Z, Weng H, Su R, Weng X, et al., FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase, Cancer Cell. 2017; 31(1): 127-141. doi: 10.1016/j.ccell.2016.11.017.

Mabrey FL, Chien SS, et al. High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia, Abstract 180 at the 60th Annual Meeting of the American Society of Hematology.

Marchesi F, Avvisati G. Leucemia Acuta Mieloide dell’adulto, Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL) Onlus, consultato il 10 Gennaio 2019

National Comprehensive Cancer Network NCCN. Clinical Practice Guidelines in Oncology - Acute myeloid leukemia (Ultimo accesso 09 Gennaio 2019).

Pallister CJ and Watson MS. Acute Leukaemias. In: Haematology, 2nd ed. Oxford, Scion Publishing.

Saleh N. Screening LSCs For AML Drug Resistance, Sensitivity, Cancer Network, 30 Novembre 2018.

Visani G, Manti A, Valentini L, Canonico B, Loscocco F, Isidori A, Gabucci E, Gobbi P, Montanari S, Rocchi M, Papa S, Gatti AM, Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia, Leuk. Res. 2016; 50: 50–56. doi: 10.1016/j.leukres.2016.09.004.

Visani G, Loscocco F, Isidori A, Nanomedicine Strategies for Hematological Malignancies: What Is Next?, MedScape, Nanomedicine. 2014; 9 (15): 2415-2428.

Wang H, Chu TT, Han SY, et al. FLT3-ITD and CEBPA Mutations Predict Prognosis in Acute Myelogenous Leukemia Irrespective of Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018. doi: 10.1016/j.bbmt.2018.11.031.

Wintrobe MM, Greer JP. Acute myeloid leukemia in adults. In: Wintrobe’s Clinical Hematology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009. p.1843-88.

Utah Physicians for a Healthy EnvironmentResearch paper of the month (Ultimo accesso 31 Dicembre 2018).

Sindrome mielodisplastica #MDS

American Cancer Society. Survival Statistics for Myelodysplastic Syndromes (Ultimo accesso 15 Dicembre 2018).

Associazione Italiana contro le Leucemie-Linfomi e Mieloma AILSindromi mielodisplastiche (Ultimo accesso 14 Dicembre 2018).

Besa EC, Myelodysplastic SyndromeMedScape, 25 Luglio 2018

Cancer.Net. Myelodysplastic Syndromes – MDS: Introduction (Ultimo accesso 06 Febbraio 2019).

Fondazione IRCCS Policlinico San MatteoSindromi mielodisplastiche (Ultimo accesso 16 Dicembre 2018).

Fondazione Malattie del Sangue FMSSindromi mielodisplastiche (Ultimo accesso 16 Dicembre 2018).

Han SJ, Survival Rates and Outlook for Myelodysplastic Syndrome (MDS), Healthline, consultato il 16 Dicembre 2018

Lindsley RC, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med, 2017; 376: 536-547. doi: 10.1056/NEJMoa1611604

Osservatorio Malattie Rare OMARSindromi mielodisplastiche, realizzata la prima mappatura italiana, 23 Agosto 2018.

Rete Ematologica Lombarda RELSindromi mielodisplastiche (Ultimo accesso 16 Dicembre 2018).

Tutte le Patologie

3 Steps Toward Preventing Infections During Cancer Treatment. Basic Hygiene Practices During Chemotherapy (Ultimo accesso 22 Gennaio 2019).

Agency for Healthcare Research and Quality AHRQ. Before Your Appointment (Ultimo accesso 23 Gennaio 2019).

Agency for Healthcare Research and Quality AHRQ. During Your Appointment (Ultimo accesso 23 Gennaio 2019).

Agenzia Italiana del Farmaco AIFA. Aderenza alle terapie e strategie per migliorare l’uso sicuro ed efficace dei farmaci (Ultimo accesso 10 Gennaio 2019).

Agenzia Italiana del Farmaco (AIFA). Criteri per la classificazione dei farmaci innovativi e dei farmaci oncologici innovativi (Ultimo accesso 01 Febbraio 2019).

American Cancer Society. Nutrition for the Person With Cancer During Treatment (Ultimo accesso 29 Gennaio 2019).

American Cancer Society. Physical Activity and the Cancer Patient (Ultimo accesso 01 Aprile 2019).

American Institute for Cancer Research. AICR's Foods that Fight Cancer (Ultimo accesso 11 Dicembre 2018).

Associazione Italiana di Oncologia Medica (AIOM). Al Senato il rapporto sullo "Stato dell'oncologia in Italia 2017", comunicato stampa del 27 Aprile 2017.

Associazione Italiana di Oncologia Medica (AIOM). I numeri del cancro in Italia 2018 (Ultimo accesso 31 Gennaio 2019).

Associazione Italiana di Oncologia Medica AIOM. Linee Guida: Preservazione della fertilità nei pazienti oncologici, edizione 2018.

Associazione Italiana Malati di Cancro AIMaC. Come potete aiutare voi stessi, 15 Aprile 2010.

Associazione Italiana Malati di Cancro AIMaC. La fatigue (Ultimo accesso 03 Gennaio 2019).

Associazione Italiana Malati di Cancro AIMaC. La nutrizione nel malato oncologico, Aprile 2017.

Associazione Italiana per la Ricerca sul Cancro AIRC. L'alimentazione (Ultimo accesso 09 Gennaio 2019).

Associazione Italiana per la Ricerca sul Cancro AIRC. Curare il cancro a tavola, 22 Ottobre 2015.

Associazione italiana registri tumori AIRTUM. I tumori in Italia. Rapporto 2006. 2006; (suppl 2): 94-95.

Associazione italiana registri tumori AIRTUM. I tumori in Italia. Rapporto AIRTUM 2010. 2010; (suppl 2): 140-141 (Ultimo accesso 1 Dicembre 2015).

Associazione Ricerca Terapie Oncologiche Integrate ARTOI, Nutrizione, 2011.

Balasso T, Anxiety and depression a major issue for cancer survivors, EurekAlert!, comunicato stampa del 17 Dicembre 2016.

Baugh EJ, Humphries D. Can we talk? Improving Couples’ Communication. University of Florida, 2010.

Blood-Cancer.com. The Life-Changing Impact of Blood Cancer (Ultimo accesso 13 Giugno 2018).

Boccadoro M, Tumori del sangue: i pazienti sopravvivono ma il sistema collassaIl Sole 24 Ore, 12 Maggio 2017.

Bolte S. Your Sexual Health and Cancer: What to Know, What to Do, Cancer.Net, 16 Marzo 2017.

Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer, 2018; 118: 1130-1141. doi: 10.1038/s41416-018-0029-6

Cancer Council NSW. Staying healthy after treatment (Ultimo accesso 23 Marzo 2019).

Cancer Fighting FoodsOncology Nutrition, 16 Marzo 2014.

Cancer.Net. Sexual Health and Cancer Treatment: Men (Ultimo accesso 05 Aprile 2019).

Cancer.Net. Sexual Health and Cancer Treatment: Women (Ultimo accesso 25 Febbraio 2019).

Cancer.Net. Tips for Managing Multiple Medications (Ultimo accesso 05 Febbraio 2019).

Cancer Research UK. About fear, anxiety and panic (Ultimo accesso 01 Febbraio 2019).

Cancer Research UK. About your emotions and cancer (Ultimo accesso 01 Febbraio 2019).

Cancer Research UK. Coping with a low sex drive (Ultimo accesso 09 Aprile 2019).

Cancer Research UK. Coping with sadness (Ultimo accesso 29 Gennaio 2019).

Cancer Research UK. Exercise guidelines for cancer patients, 2015.

Cancer Research UK. Exercise guidelines for cancer patients (Ultimo accesso 27 Marzo 2019).

Cancer Research UK. Guilt, blame and anger (Ultimo accesso 01 Febbraio 2019).

Cancer Research UK. How cancer can affect your sexuality and sex life (Ultimo accesso 01 Marzo 2019).

Cancer Research UK, How physical activity prevent cancer, 2016.

Cancer Research UK. Managing fear, anxiety and panic (Ultimo accesso 29 Gennaio 2019).

Cancer Research UK. ​More than 2,500 cancer cases a week could be avoided, comunicato stampa del 23 Marzo 2018.

Cancer Research UK. Taking medicines (Ultimo accesso 09 Gennaio 2019).

Cancer Research UK. Ways to keep your fertility (Ultimo accesso 07 Aprile 2019).

Cancer Treatment Centers of America. Super foods (Ultimo accesso 05 Febbraio 2019).

Centers for Disease Control and Prevention (CDC). Preventing infections in cancer patients (Ultimo accesso 03 Febbraio 2019).

Centers for Disease Control and Prevention (CDC). When & How to Wash Your Hands (Ultimo accesso 22 Gennaio 2019).

Conforti F, Pala L, Bagnardi V, et al. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis. Lancet Oncology, 2018; 19(6): 737-746. doi: 10.1016/S1470-2045(18)30261-4.

Consiglio per la ricerca in agricoltura e l’analisi dell’economia agraria (CREA). Linee guida del Centro di ricerca per gli alimenti e la nutrizione (CREA) (Ultimo accesso 10 Dicembre 2018).

Cook for Your Life (Ultimo accesso 11 Gennaio 2019).

Crotti N, Cuzzoni Q, Damiano A, Lucchini D, Marini G, Murru L, Petrocca S, Consigli utili per l'alimentazione nel paziente oncologico adulto in fase di trattamento, SIPO Società Italiana di Psico-Oncologia, 2011.

Obesità: Dati Epidemiologici, Epicentro (Ultimo accesso 14 Gennaio 2019).

ESMO Asia 2016 Press Release: Anxiety and Depression a Major Issue for Cancer Survivors, ESMO European Society for Medical Oncology, 18 Dicembre 2016.

Men and women are different: Why medical oncology needs to restate the obviousEuropean Society for Medical Oncology, comunicato stampa del 28 Agosto 2018.

Gilbert S, The Medical Minute: Reducing the likelihood of developing cancerPenn State University, 17 Aprile 2018

Glare P, et al., Treating nausea and vomiting in palliative care: a review, Clin Interv Aging 2011; 6: 243-259. doi: 10.2147/CIA.S13109.

Grinfeld J, Nangalia J, Baxter EJ, et al. Classification and Personalized Prognosis in Myeloproliferative Neoplasms. N Engl J Med 2018; 379: 1416-1430. doi: 10.1056/NEJMoa1716614

Heywood R, McCarthy AL, Skinner TL. Efficacy of Exercise Interventions in Patients With Advanced Cancer: A Systematic Review. Arch Phys Med Rehabil. 2018 Dec; 99(12): 2595-2620 (Abstract).

Hoekstra J, Bindels PJ, van Duijn NP, Schade E. The symptom monitor. A diary for monitoring physical symptoms for cancer patients in palliative care: feasibility, reliability and compliance. J Pain Symptom Manage 2004; 27: 24–35.

Ibn Sina AA, Carrascosa LG, Liang Z, et al. Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nature Communications, 2018; 9(art.4915): 1-13. doi: 10.1038/s41467-018-07214-w

Kawai K, Yawn BP. Risk of Herpes Zoster in Cancer Patients and the Promise of New Vaccines. The Journal of Infectious Diseases, 2018; jiy626: 1-2. doi: 10.1093/infdis/jiy626.  

Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N. Aerobic physical exercise for adult patients with haematological malignancies, Cochrane Database Syst Rev. 2019; 1: CD009075. doi: 10.1002/14651858.CD009075.pub3.

Kushi LH et al., American Cancer Society guidelines on nutrition and physical activity for cancer prevention, CA Cancer J Clin. 2012; 62(1): 30-67. doi: 10.3322/caac.20140

La sopravvivenza dei pazienti oncologici in Italia. Survival of cancer patients in Italy. Epidemiol Prev 2017; 41(2 Suppl 1) (http://www.registri-tumori.it/cms/Rapp2016Indice).

Le Riche P, New tool to find and fight most dangerous types of lymphoma, University of Leeds, comunicato stampa del 03 Dicembre 2018.

Leukemia & Lymphoma Society. Healthy lifestyle habits for a better quality of life (Ultimo accesso 26 Febbraio 2019).

Leukemia & Lymphoma Society. Sexuality and Intimacy (Ultimo accesso 28 Febbraio 2019).

Leukemia & Lymphoma Society. Infections (Ultimo accesso 22 Gennaio 2019).

Leukemia & Lymphoma Society. Managing Your Cancer - Food and Nutrition (Ultimo accesso 12 Gennaio 2019).

Leukemia & Lymphoma Society. Managing Your Cancer: Fertility (Ultimo accesso 29 Marzo 2019).

Macmillan Cancer Support. Avoiding Infection (Ultimo accesso 10 Gennaio 2019).

Macmillan Cancer Support. Benefits of being active (Ultimo accesso 22 Gennaio 2019).

Macmillan Cancer Support. Different Ways of being active (Ultimo accesso 25 Gennaio 2019).

Macmillan Cancer Support. Getting started (Ultimo accesso 25 Gennaio 2019).

Macmillan Cancer Support. Maintaining A Healthy Lifestyle (Ultimo accesso 11 Gennaio 2019).

Macmillan Cancer Support. Managing your fatigue (Ultimo accesso 23 Gennaio 2019).

Macmillan Cancer Support. Your emotions (Ultimo accesso 12 Gennaio 2019).

Magee E, The Anticancer DietWebMD, 2004.

National Cancer Institute. Managing chemotherapy side effects: Infection (Ultimo accesso 22 Gennaio 2019).

Ministero della Salute. Alimentazione corretta (Ultimo accesso 09 Gennaio 2019).

Ministero della Salute. Piano nazionale per la fertilità (Ultimo accesso 10 Aprile 2019).

Ministero della Salute. Suggerimenti utili per la sicurezza degli alimenti a casa (Ultimo accesso 10 Gennaio 2019).

National Cancer Institute. Caring for the caregiver (Ultimo accesso 30 Gennaio 2019).

National Cancer Institute. Managing chemotherapy side effects (ultimo accesso 03 Febbraio 2019).

National Cancer Institute, Nutrition in Cancer Care (PDQ®) - Patient Version, 8 Gennaio 2016.

National Health Services NHS. Easy exercises (Ultimo accesso 25 Gennaio 2019).

National Institute on Aging NIA. Why Being Able to Talk to Your Doctor Matters (Ultimo accesso 09 Gennaio 2019).

Northouse L, Williams A, Given B, McCorkle R. Psychosocial care for family caregivers of patients with cancer. J Clin Oncol. 2012;30:1227–1234. doi: 10.1200/JCO.2011.39.5798.

Osterberg L and Blaschke T, Adherence to medication. N Engl J Med. 2005; 353: 487–497.

Özdemir BC, Csajka C, Dotto GP, Wagner AD. Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology. J Clin Oncol. 2018; 36(26): 2680-2683. doi: 10.1200/JCO.2018.78.3290.

Physical Activity Associated with Lower Risk of Many Cancers, The JAMA Network Journals, comunicato stampa del 16 Maggio 2018.

Qian J, Heywood AE, Karki S, et al. Risk of Herpes Zoster Prior to and Following Cancer Diagnosis and Treatment: A Population-Based Prospective Cohort Study. The Journal of Infectious Diseases, 2018; jiy625: 1-9. doi: 10.1093/infdis/jiy625.

Redd WH, Montgomery GH, DuHamel KN, Behavioral Intervention for Cancer Treatment Side Effects, JNCI J Natl Cancer Inst 2001; 93(11): 810-823. doi: 10.1093/jnci/93.11.810.

Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA: A Cancer Journal for Clinicians 2012; 62(4):243-274. [PubMed Abstract].

Roila F et al., Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference, Ann. Oncol. 2010; 21(5): v232-v243. doi: 10.1093/annonc/mdq194.

Ruddy K, et al. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59: 56–66.

Sampson D, Excess body weight responsible for nearly 4 percent of cancers worldwide, American Cancer Society, comunicato stampa del 12 Dicembre 2018.

Schnell F, Chemotherapy-Induced Nausea and Vomiting: The Importance of Acute Antiemetic Control, Oncologist 2013; 8(2): 187–198. doi: 10.1634/theoncologist.8-2-187.

Sha C, Barrans S, Cucco F, et al. Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy. Journal of Clinical Oncology 2018. doi: 10.1200/JCO.18.01314.

Simon S, 6 Steps to Help Lower Your Cancer RiskAmerican Cancer Society, 20 Marzo 2017.

Sina A, McMillan F. Nano-signature discovery could revolutionise cancer diagnosis, The University of Queensland Australia, comunicato stampa del 05 Dicembre 2018.

Smith KB, Pukall CF. An evidence-based review of yoga as a complementary intervention for patients with cancer, University of York Center for Reviews and Dissemination (Ultimo accesso 27 Marzo 2019).

Stenberg U, Ruland CM, Miaskowski C. Review of the literature on the effects of caring for a patient with cancer. Psychooncology. 2009;19:1013–1025. doi: 10.1002/pon.1670.

Sung H, Siegel R, Torre LA, et al. Global Patterns in Excess Body Weight and the Associated Cancer Burden.  CA Cancer J Clin 2018; 0: 1–25. doi: 10.3322/caac.21499

Swerdlow S et al. Lymphoplasmacytic Lymphoma. In: Swerdlow S et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon,France: International Agency for Research on Cancer; 2008: p194-5.

Van de Donk NW et al. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. Haematologica 2014.

World Cancer Day. About World Cancer Day (Ultimo accesso 31 Gennaio 2019).

World Cancer Research Fund International. Cancer Prevention Recommendations (Ultimo accesso 06 Febbraio 2019).

World Health Organization WHO. Adherence to long-term therapies – evidence for action (Ultimo accesso 29 Gennaio 2019).

World Health Organization (WHO). Cancer, 12 Settembre 2018.

Yu H, Li L, Liu C, et al. Factors associated with the quality of life of family caregivers for leukemia patients in China. Health and Quality of Life Outcomes. 2017; 15:55. doi:10.1186/s12955-017-0628-6 http://ascopubs.org/doi/pdf/10.1200/JCO.2011.39.5798.